DIE LEUKOZYTENTRANSFUSION = LA TRANSFUSION DE LEUCOCYTESBORBERG H.1980; KLIN. ANAESTHESIOL. INTENSIVTHERAP.; DEU; DA. 1980; VOL. 21; PP. 197-206; BIBL. 20 REF.Article

Extrakorporale Eliminationsbehandlung von Autoimmunkrankungen = Extracorporeal elimination treatment in autoimmune diseasesBORBERG, H.Klinische Anästhesiologie und Intensivtherapie. 1993, Vol 45, pp 184-200, issn 0341-5023Article

DIE BCG-BEHANDLUNG DES MALIGNEN MELANOMS. = LE TRAITEMENT PAR LE BCG DES MELANOMES MALINSBORBERG H.1975; INTERNIST; DTSCH.; DA. 1975; VOL. 16; NO 10; PP. 482-485; BIBL. 38 REF.Article

BEHANDLUNG MIT GRANULOZYTENTRANSFUSIONEN. = TRAITEMENT PAR TRANSFUSIONS DE GRANULOCYTESSCHMITZ VALCKENBERG M; BORBERG H.1976; DTSCHE MED. WSCHR.; DTSCH.; DA. 1976; VOL. 101; NO 40; PP. 1458-1460; BIBL. 16 REF.Article

PLATELETPHERESIS WITH THE IBM MODEL 2997. I: EFFECTS OF ACD, NIH FORMULA B ON SELECTED DONOR INDICESMISHLER JM; LUND P; BORBERG H et al.1980; VOX SANG.; CHE; DA. 1980; VOL. 38; NO 1; PP. 36-39; BIBL. 11 REF.Article

PLASMAAUSTAUSCH-THERAPIE BEI DERMATOLOGISCHEN ERKRANKUNGEN. LITERATURUEBERSICHT UND EIGENE ERFAHRUNGEN BEI DER PSORIASIS VULGARIS = ECHANGE PLASMATIQUE DANS LES AFFECTIONS DERMATOLOGIQUES. REVUE DE LA LITTERATURE ET EXPERIENCE PERSONNELLE DANS LE PSORIASISKLEMM MAYER H; STERRY W; BORBERG H et al.1983; H+G. ZEITSCHRIFT FUER HAUTKRANKHEITEN; ISSN 0301-0481; DEU; DA. 1983; VOL. 58; NO 15; PP. 1085-1094; 8 P.; ABS. ENG; BIBL. 27 REF.Article

APPLICATION OF SPECIFIC EXTRACORPOREAL REMOVAL OF LOW DENSITY LIPOPROTEIN IN FAMILIAL HYPERCHOLESTEROLAEMIASTOFFEL W; BORBERG H; GREVE V et al.1981; LANCET (BR. ED.); ISSN 0140-6736; GBR; DA. 1981; NO 8254; PP. 1005-1007; BIBL. 23 REF.Article

THE CATABOLISM OF LOW MOLECULAR WEIGHT-HYDROXYETHYLATED AMYLOPECTIN IN MAN. II: CHANGES IN THE URINARY MOLECULAR PROFILESMISHLER JM; RICKETTS CR; PARKHOUSE EJ et al.1980; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1980; VOL. 18; NO 1; PP. 5-9; BIBL. 11 REF.Article

HYDROXYETHYL STARCH. AN AGENT FOR HYPOVOLAEMIC SHOCK TREATMENT II. URINARY EXCRETION IN NORMAL VOLUNTEERS FOLLOWING THREE CONSECUTIVE DAILY INFUSIONS.MISHLER JM; BORBERG H; EMERSON PM et al.1977; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1977; VOL. 4; NO 5; PP. 591-595; BIBL. 24 REF.Article

IN VITRO GRANULOCYTE FUNCTION AS AFFECTED BY FILTER LOADING TIME AND TAPPING DURING FILTRATION LEUKAPHERESISSTEGMANN G; MISHLER JM; MATTELE HL et al.1980; VOX SANG.; CHE; DA. 1980; VOL. 38; NO 4; PP. 191-196; BIBL. 12 REF.Article

GRAFT-VERSUS-HOST-REAKTION NACH GRANULOZYTENTRANSFUSION VON EINEM NORMALSPENDER. = REACTION GREFFON. ROLE APRES TRANSFUSION DE GRANULOCYTES D'UN DONNEUR NORMALSALFNER B; BORBERG H; KRUGER G et al.1978; BLUT; DTSCH.; DA. 1978; VOL. 36; NO 1; PP. 27-34; ABS. ANGL.; BIBL. 11 REF.Article

THE UTILIZATION OF A NEW STRENGTH CITRATE ANTICOAGULANT DURING CENTRIFUGAL PLATELETPHERESIS. II. ASSESSMENT OF IN VITRO PLATELET FUNCTION.MISHLER JM; BORBERG H; REUTER H et al.1977; BLUT; DTSCH.; DA. 1977; VOL. 34; NO 3; PP. 237-241; ABS. ALLEM.; BIBL. 9 REF.Article

INHIBITION OF ESTABLISHED TRANSPLANTS OF CHEMICALLY INDUCED SARCOMAS IN SYNGENEIC MICE BY LYMPHOCYTES FROM IMMUNIZED DONORS = INHIBITION DE TRANSPLANTS ETABLIS DE SARCOMES INDUITS CHIMIQUEMENT CHEZ DES ROURIS SYNGENIQUES PAR LES LYMPHOCYTES DE DONNEURS IMMUNISESBORBERG H; OETTGEN HF; CHOUDRY K et al.1972; INTERNATION. J. CANCER; SWITZ.; DA. 1972; VOL. 10; NO 3; PP. 539-547; ABS. FR.; BIBL. 11 REF.Serial Issue

ELEMENTAL COMPOSITION OF PLATELETS. III: DETERMINATION OF AG, AU, CD, CO, CR, CS, MO, RB, SB, AND SE IN NORMAL HUMAN PLATELETS BY NEUTRON ACTIVATION ANALYSISKASPEREK K; GOVINDARAJA VENKATESH TYENGAR; KIEM J et al.1979; CLIN. CHEM.; USA; DA. 1979; VOL. 25; NO 5; PP. 711-715; BIBL. 29 REF.Article

Untersuchungen zur Sicherheit der apparativen Zytapherese = Etudes de la sécurité de la cytophérèse = Analysis of the safety of cytopheresis with cell separatorsBÖHM, R; BORBERG, H.Infusionstherapie und klinische Ernährung. 1987, Num 14, pp 18-27, issn 0378-0791, suppl. 4Article

Inhibition of tumor growth in a mouse fibrosarcoma after interleukin 2 applicationBORBERG, H; ABDALLAH, A; SCHWULERA, U et al.Immunobiology (1979). 1986, Vol 172, Num 3-4-5, pp 383-390, issn 0171-2985Article

ZUR BEHANDLUNG DES GOODPASTURE SYNDROMS. = LE TRAITEMENT DU SYNDROME DE GOODPASTUREBORBERG H; KINDLER J; MAHIEU B et al.1978; MED. WELT; DTSCH.; DA. 1978; VOL. 29; NO 13; PP. 545-547; BIBL. 10 REF.Article

Anaphylatoxin generation and distribution during in vitro LDL apheresisPARUSEL, M; KADAR, J. G; BORBERG, H et al.Infusionstherapie (1988). 1992, Vol 19, Num 5, pp 245-248, issn 1011-6966Article

Anticoagulation-dependent inhibition of in vitro complement activation by anti-Apo-B sepharose 4B CL = Anticoagulation-dependant inhibition of in vitro complement activation by anti-ApoB sepharose 4B CLKADAR, J. G; PARUSEL, M; BORBERG, H et al.Infusionstherapie (1988). 1992, Vol 19, Num 5, pp 237-240, issn 1011-6966Article

GRANULOCYTE TRANSFUSIONS: AN ESTABLISHED OR STILL AN EXPERIMENTAL THERAPEUTIC PROCEDURE.BENBUNAN M; BORBERG H; FORTUNY I et al.1980; VOX SANG.; CHE; DA. 1980; VOL. 38; NO 1; PP. 40-58; BIBL. DISSEM.Article

ERGEBNISSE DER SYNCHRONISATIONSTHERAPIE MIT VINCRISTIN UND CYCLOPHOSPHAMID BEI LYMPHOGRANULOMATOSE, RETIKULUMZELL- UND LYMPHOSARKOM. EINE PHASE. II. STUDIE. = RESULTATS DU TRAITEMENT PAR SYNCHRONISATION PAR LA VINCRISTINE, ET LE CYCLOPHOSPHAMIDE DE LA LYMPHOGRANULOMATOSE, DES RETICULARCOMES ET DES LYMPHOSARCOMES. ETUDE EN PHASE IIKLEIN HO; GERECKE D; BORBERG H et al.1975; DTSCHE MED. WSCHR.; DTSCH.; DA. 1975; VOL. 100; NO 35; PP. 1719-1726; ABS. ANGL.; BIBL. 57 REF.Article

Einsatz extrakorporaler Behandlungsverfahren bei ausgewählten Augenerkrankungen. Kommentar = Extracorporeal treatment procedures for selected ocular diseases. CommentaryBRUNNER, R; WIDDER, R. A; BORBERG, H et al.Der Ophthalmologe (Berlin. Print). 1999, Vol 96, Num 10, pp 679-683, issn 0941-293XArticle

Beeinflussung hämorrheologischer und laborchemischer Parameter durch Infusionstherapie mit Serumkonserve und durch Plasmaaustausch mit Human-albumin und Serumkonserve bei Patienten mit Uveitis posterior und intermedia = Effets hémorhéologiques des échanges plasmatiques avec de la sérumalbumine et du sérum conservé et des perfusions par du sérum conservé chez des patients atteints d'uvéite postérieure et intermédiaire = Haemorrheological effects of plasma exchange with human albumin and serum preserve and infusion therapy with serum preserve in patients with uveitis posterior and intermediaJAHN, M; BRUNNER, R; BORBERG, H et al.Fortschritte der Ophthalmologie. 1988, Vol 85, Num 6, pp 740-743, issn 0723-8045Conference Paper

Sequential treatment of Guillain-Barré syndrome with extracorporeal elimination and intravenous immunoglobulinHAUPT, W. F; ROSENOW, F; VAN DER VEN, C et al.Journal of the neurological sciences. 1996, Vol 137, Num 2, pp 145-150, issn 0022-510X, 5 p.Article

Plasmaaustauschbehandlung bei chronischen Polyneuritiden vom Typ Guillain-Barré. Erfahrungen mit neuneigenen Fällen = Echange plasmatique chez 9 malades avec syndrome de Guillain-Barré = Plasma exchange in 9 cases of Guillain-Barre syndromeGIBBELS, E; TOYKA, K. V; BORBERG, H et al.Nervenarzt. 1986, Vol 57, Num 3, pp 129-139, issn 0028-2804Article